Oh yeah a real,company.....Dabney said this a while ago...perhaps investors need to speak to him and ask him if he was defrauding them with false and misleading news...or perhaps he should actually add the names of these select clinics to the Cbis website....lmao...hey dabney ,the balls in your court..are you hung up on the packaging...the website hasn't been added to to receive these new clinical patients...you really are a pos stock scammer Dabney ...please call the Cbis people today and share what story they have aboit their most recent failure to execute...how many shares did you and Kane sell in this news story Dabney ...lmao
IRVINE, CA--(Marketwired - Sep 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is excited to announce they have received their initial batch of nebulizers for their cannabinoid-based MDI rescue inhalers, which targets asthma/COPD for legal self-medicating patients. Previous third-party studies using cannabis-based treatments for asthma/COPD have shown positive results with fewer side effects, and that has spurred the company to move to market as quickly as possible to capitalize on the infancy of the market.
In addition to select dispensaries in California, the company will be testing the initial batch out with 20-25 legal self-medicating candidates suffering from asthma/COPD and other respiratory ailments in the State of California. The observational study will allow the company to confirm observation efficacy, develop additional marketing materials, and improve product design while building a wider spread release.
AI
